Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

COVID-19

Free Subscription 25.03.2024 2 Acad Emerg Med 1 Antiviral Res 1 BMJ 5 Clin Infect Dis 1 Graefes Arch Clin Exp Ophthalmol 2 Infect Control Hosp Epidemiol 2 J Infect 17 J Med Virol 4 J Virol 6 JAMA 1 MMWR Morb Mortal Wkly Rep 3 Nature

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acad Emerg Med

1. REISDORFF EJ, Johnston MM, Lall MD, Lu DW, et al
   Prospective validity evidence for the abbreviated emergency medicine Copenhagen Burnout Inventory.
   Acad Emerg Med. 2024 Mar 17. doi: 10.1111/acem.14892.
   PubMed         Abstract available
   
   
2. JOHARI F, Verma R
   Paxlovid for nonhospitalized patients with COVID-19.
   Acad Emerg Med. 2024 Mar 22. doi: 10.1111/acem.14896.
   PubMed        
   
   

   
   Antiviral Res

3. MOON C, Porges E, Roberts A, Bacon J, et al
   A combination of nirmatrelvir and ombitasvir boosts inhibition of SARS-CoV-2 replication.
   Antiviral Res. 2024 Mar 14:105859. doi: 10.1016/j.antiviral.2024.105859.
   PubMed         Abstract available
   
   

   
   BMJ

4. MCKEEVER V
   Long covid and myalgic encephalomyelitis/chronic fatigue syndrome are overlapping conditions.
   BMJ. 2024;384:q613.
   PubMed        
   
   

   
   Clin Infect Dis

5. GUPTA A, Hughes MD, Cruz JL, Avihingsanon A, et al
   Adverse Pregnancy Outcomes among HIV-infected Women Taking Isoniazid Preventive Therapy During the First Trimester.
   Clin Infect Dis. 2023 Sep 28:ciad583. doi: 10.1093.
   PubMed         Abstract available
   
   
6. GOHEEN MM
   Growing Up COVID.
   Clin Infect Dis. 2024;78:496-498.
   PubMed        
   
   
7. STIER EA, Jain M, Joshi H, Darragh TM, et al
   Two-Year Incidence and Cumulative Risk and Predictors of Anal High-Grade Squamous Intraepithelial Lesions (anal precancer) among Women with HIV.
   Clin Infect Dis. 2023 Oct 8:ciad614. doi: 10.1093.
   PubMed         Abstract available
   
   
8. CARAZO S, Guay CA, Skowronski DM, Amini R, et al
   Influenza hospitalization burden by subtype, age, comorbidity and vaccination status: 2012/13 to 2018/19 seasons, Quebec, Canada.
   Clin Infect Dis. 2023 Oct 11:ciad627. doi: 10.1093.
   PubMed         Abstract available
   
   
9. KOLBERG L, Khanijau A, van der Velden FJS, Herberg J, et al
   Raising AWaRe-ness of Antimicrobial Stewardship Challenges in Pediatric Emergency Care: Results from the PERFORM Study Assessing Consistency and Appropriateness of Antibiotic Prescribing Across Europe.
   Clin Infect Dis. 2024;78:526-534.
   PubMed         Abstract available
   
   

   
   Graefes Arch Clin Exp Ophthalmol

10. VON DER BURCHARD C, Gruben A, Roider J
    Optical coherence tomography angiography suggests choriocapillaris perfusion deficit as etiology of acute macular neuroretinopathy.
    Graefes Arch Clin Exp Ophthalmol. 2024 Mar 21. doi: 10.1007/s00417-024-06436.
    PubMed         Abstract available
    
    

    
    Infect Control Hosp Epidemiol

11. SCHMITZ E, Anderson L, Hatas G, Stevens L, et al
    Population and hospital-level COVID-19 measures are associated with increased risk of hospital-onset COVID-19.
    Infect Control Hosp Epidemiol. 2024 Mar 18:1-3. doi: 10.1017/ice.2024.
    PubMed         Abstract available
    
    
12. JOSHI S, Arshad S, Lindsay A, Heinonen J, et al
    Control of SARS-CoV-2 infection in skilled nursing facilities in Detroit, Michigan: a model for emerging infectious diseases.
    Infect Control Hosp Epidemiol. 2024 Mar 20:1-3. doi: 10.1017/ice.2024.
    PubMed         Abstract available
    
    

    
    J Infect

13. SUN L, Man Q, Zhang H, Xia S, et al
    Strong cross immune responses against sarbecoviruses but not merbecoviruses in SARS-CoV-2 BA.5/BF.7-infected individuals with or without inactivated COVID-19 vaccination.
    J Infect. 2024;88:106138.
    PubMed        
    
    
14. SALMAN M, Rana MS, Usman M, Tahir M, et al
    Re-emergence of Diphtheria after COVID-19 Pandemic in Pakistan: time to consider booster vaccination strategies.
    J Infect. 2024 Mar 19:106141. doi: 10.1016/j.jinf.2024.106141.
    PubMed        
    
    

    
    J Med Virol

15. ROBERTS SC, Jolley SE, Beaty LE, Aggarwal NR, et al
    Association between monoclonal antibody therapy, vaccination, and longer-term symptom resolution after acute COVID-19.
    J Med Virol. 2024;96:e29541.
    PubMed         Abstract available
    
    
16. DE AGUIRRE PM, Carlos S, Pina-Sanchez M, Mbikayi S, et al
    High pre-Delta and early-Omicron SARS-CoV-2 seroprevalence detected in dried blood samples from Kinshasa (D.R. Congo).
    J Med Virol. 2024;96:e29529.
    PubMed         Abstract available
    
    
17. TRANTER E, Frentsch M, Hutter-Kronke ML, Vuong GL, et al
    Comparable CD8(+) T-cell responses to SARS-CoV-2 vaccination in single-cell transcriptomics of recently allogeneic transplanted patients and healthy individuals.
    J Med Virol. 2024;96:e29539.
    PubMed         Abstract available
    
    
18. ZHOU J, Zhou Y, Wei XF, Fan L, et al
    TRIM6 facilitates SARS-CoV-2 proliferation by catalyzing the K29-typed ubiquitination of NP to enhance the ability to bind viral genomes.
    J Med Virol. 2024;96:e29531.
    PubMed         Abstract available
    
    
19. JITOBAOM K, Peerapen P, Boonyuen U, Meewan I, et al
    Identification of inositol monophosphatase as a broad-spectrum antiviral target of ivermectin.
    J Med Virol. 2024;96:e29552.
    PubMed         Abstract available
    
    
20. HUANG M, Cui T, Liu S, Su X, et al
    Blended BA.5 infection within 8 days after a boosted bivalent mRNA vaccination strengthens and lengthens the host immunity.
    J Med Virol. 2024;96:e29544.
    PubMed         Abstract available
    
    
21. ZHANG H, Guo H
    Optimization of a DNA-launched SARS-CoV-2 replicon with RNA splicing inhibitor Isoginkgetin.
    J Med Virol. 2024;96:e29547.
    PubMed         Abstract available
    
    
22. ZHA G, Chen Z, Wu N, Huang T, et al
    Clinical characteristics and immunogenicity after Omicron breakthrough infection in patients with chronic hepatitis B infection: A longitudinal observational study.
    J Med Virol. 2024;96:e29548.
    PubMed         Abstract available
    
    
23. KUO YM, Kang CM, Lai ZY, Huang TY, et al
    Temporal changes in biomarkers of neutrophil extracellular traps and NET-promoting autoantibodies following adenovirus-vectored, mRNA, and recombinant protein COVID-19 vaccination.
    J Med Virol. 2024;96:e29556.
    PubMed         Abstract available
    
    
24. ZEDAN HT, Smatti MK, Al-Sadeq DW, Al Khatib HA, et al
    SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines.
    J Med Virol. 2024;96:e29527.
    PubMed         Abstract available
    
    
25. FU X, Wang Z, Chen B, Sun H, et al
    Detection of SARS-CoV-2 virus in middle ear effusions and its association with otitis media with effusion.
    J Med Virol. 2024;96:e29545.
    PubMed         Abstract available
    
    
26. FROHLICH GC, Gregianini TS, Pinheiro FG, Nascimento R, et al
    Resurgence of human respiratory syncytial virus during COVID-19 pandemic in Southern Brazil.
    J Med Virol. 2024;96:e29551.
    PubMed         Abstract available
    
    
27. HUNG KC, Lin HJ, Chen IW
    New-onset neurodegenerative diseases following SARS-CoV-2 infection: An analysis of prediction interval.
    J Med Virol. 2024;96:e29563.
    PubMed        
    
    
28. WANG A
    Integrating Frechet distance and AI reveals the evolutionary trajectory and origin of SARS-CoV-2.
    J Med Virol. 2024;96:e29557.
    PubMed         Abstract available
    
    
29. HUANG J, Qiu Y, Luo L, Wu J, et al
    Long-term immunogenicity and safety of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants who had received two or three doses of inactivated vaccine.
    J Med Virol. 2024;96:e29542.
    PubMed         Abstract available
    
    
30. BROGNA C, Montano L, Zanolin ME, Bisaccia DR, et al
    A retrospective cohort study on early antibiotic use in vaccinated and unvaccinated COVID-19 patients.
    J Med Virol. 2024;96:e29507.
    PubMed         Abstract available
    
    
31. ZHENG L, Wang H, Liu X, Xu C, et al
    A panel of multivalent nanobodies broadly neutralizing Omicron subvariants and recombinant.
    J Med Virol. 2024;96:e29528.
    PubMed         Abstract available
    
    

    
    J Virol

32. YANG Y-L, Wang B, Li W, Cai H-L, et al
    Functional dissection of the spike glycoprotein S1 subunit and identification of cellular cofactors for regulation of swine acute diarrhea syndrome coronavirus entry.
    J Virol. 2024 Mar 19:e0013924. doi: 10.1128/jvi.00139.
    PubMed         Abstract available
    
    
33. MAI F, Bergmann W, Reisinger EC, Muller-Hilke B, et al
    The varying extent of humoral and cellular immune responses to either vector- or RNA-based SARS-CoV-2 vaccines persists for at least 18 months and is independent of infection.
    J Virol. 2024 Mar 19:e0191223. doi: 10.1128/jvi.01912.
    PubMed         Abstract available
    
    
34. WANG T, Hu L, Li R, Ren H, et al
    Hyperoside inhibits EHV-8 infection via alleviating oxidative stress and IFN production through activating JNK/Keap1/Nrf2/HO-1 signaling pathways.
    J Virol. 2024 Mar 19:e0015924. doi: 10.1128/jvi.00159.
    PubMed         Abstract available
    
    
35. WANG X, Tong W, Yang X, Zhai H, et al
    RBM14 inhibits the replication of porcine epidemic diarrhea virus by recruiting p62 to degrade nucleocapsid protein through the activation of autophagy and interferon pathway.
    J Virol. 2024;98:e0018224.
    PubMed         Abstract available
    
    

    
    JAMA

36. HARRIS E
    COVID-19 Infection Tied to Slight Cognitive Deficits.
    JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2087.
    PubMed        
    
    
37. HARRIS E
    COVID-19 Associated With Higher Risk of Autoimmune Diseases.
    JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2092.
    PubMed        
    
    
38. LU Y, Matuska K, Nadimpalli G, Ma Y, et al
    Stroke Risk After COVID-19 Bivalent Vaccination Among US Older Adults.
    JAMA. 2024;331:938-950.
    PubMed         Abstract available
    
    
39. NIELSEN FM, Klitgaard TL, Siegemund M, Laake JH, et al
    Lower vs Higher Oxygenation Target and Days Alive Without Life Support in COVID-19: The HOT-COVID Randomized Clinical Trial.
    JAMA. 2024 Mar 19:e242934. doi: 10.1001/jama.2024.2934.
    PubMed         Abstract available
    
    
40. SCHWARTZSTEIN RM
    Oxygen Supplementation in COVID-19-How Much Is Enough?
    JAMA. 2024 Mar 19. doi: 10.1001/jama.2024.2935.
    PubMed        
    
    
41. GRAETZ N, Hepburn P, Gershenson C, Porter SR, et al
    Examining Excess Mortality Associated With the COVID-19 Pandemic for Renters Threatened With Eviction.
    JAMA. 2024;331:592-600.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

42. WILLIAMS SL, Smith DJ, Benedict K, Ahlers JR, et al
    Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis During the COVID-19 Pandemic - United States, 2019-2021.
    MMWR Morb Mortal Wkly Rep. 2024;73:239-244.
    PubMed         Abstract available
    
    

    
    Nature

43. KIM SE
    Four years on: the career costs for scientists battling long COVID.
    Nature. 2024;627:689-691.
    PubMed        
    
    
44. LOPEZ LLOREDA C
    COVID's toll on the brain: new clues emerge.
    Nature. 2024 Mar 20. doi: 10.1038/d41586-024-00828.
    PubMed        
    
    
45. LENHARO M
    Google AI could soon use a person's cough to diagnose disease.
    Nature. 2024 Mar 21. doi: 10.1038/d41586-024-00869.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.